CFO and Whole-time Director Himanshu Agarwal resigns from Cohance
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts less than Nifty Smallcap 250 and 3.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. Himanshu Agarwal, Whole-time Director and Chief Financial Officer (Key Managerial Personnel) of Cohance Lifesciences, has resigned to pursue a professional opportunity outside the company. His resignation was tendered on 17 June 2026 and he will be relieved from duties at close of business on 13 September 2026, giving roughly a three-month transition. He confirmed there are no other material reasons and has committed to an orderly handover.
Loss of a key leadership and finance role; nearly three-month transition should help, but watch for succession announcement.